Optimal Fluid Selection for Shock Resuscitation

Friday, May 1, 2026, 7:30 AM - Saturday, May 1, 2027, 12:30 PM


AMA PRA Category 1 Credits™ (0.50 hours), AMA PRA Category 1 Credit™ Designated Non-Physician Participation Certification (0.50 hours), ANCC Contact Hours (0.50 hours), IPCE Credits (0.50 hours)

Optimal Fluid Selection for Shock Resuscitation was part of the 2025 Critical Care Update conference, which was an engaging and collaborative course planned and implemented by physicians, nurses, and pharmacists. The event was specifically geared toward physicians, nurses, and pharmacists practicing in anesthesiology, critical care, emergency medicine, general surgery, and pulmonology, as well as those in family, general, hospital, and internal medicine. Moreover, it may also be of great interest to physician assistants, emergency medical technicians, respiratory therapists, and other healthcare professionals involved in providing care for critically ill patients.

This lecture course will focus on the implementation of new strategies for fluid resuscitation in shock. By participating in this online activity, attendees can expect to gain increased knowledge, enhance their competence, improve their performance, and ultimately elevate the quality of care provided to adult critical care patients. This event serves as a platform for attendees to exchange insights, explore the latest advancements, and foster collaborative learning, all with the shared goal of optimizing patient outcomes in the critical care setting.

1. Apply state of the art fluid resuscitation management to critically ill patients with shock
2. Advocate for the application of appropriate vasopressor use in the ICU setting.
3. Formulate a plan for the use of neuroprotection in critically ill shock patients.
4. Calculate and assess the risk benefit of pharmacologic reversal of bleeding in shock.
5. Formulate local protocols for the optimal treatment of cardiogenic shock.
6. Apply evidence-based approaches to the treatment of patients with septic shock.

In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credits Available for this Activity:

American Medical Association (AMA)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 0.50 ANCC contact hours.

Interprofessional Continuing Education (IPCE)
This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credits for learning and change.

Course Director
Marin H. Kollef, MD, FACP, FCCP

Presented By
The Division of Pulmonary & Critical Care Medicine
Washington University School of Medicine in St. Louis

 

The Washington University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Washington University School of Medicine in St. Louis adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

This activity is supported in part by

This activity may be supported in part by educational grants from various commercial organizations. A complete list of commercial supporters will be available at the time of the conference. Some companies may also exhibit.

Abiomed / Johnson & Johnson

Baxter Healthcare Corporation

Platinum

Gold

Octapharma

Silver

AbbVie

Mallinckrodt Pharmaceuticals

Bronze

Merck